文艺复兴科技 对 GILD 的持仓历史
GILEAD SCIENCES INC · 医疗保健
文艺复兴科技 在 Q3 2026 的 13F 申报中披露持有 GILD(GILEAD SCIENCES INC)2,054,876 股,市值约 US$306.3M,约占其申报组合的 0.42%,在其申报持仓中市值排名第 31 位。 文艺复兴科技 最近 54 个申报季度中有 51 个季度披露了 GILD 持仓,最早可追溯至 Q2 2013。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
文艺复兴科技 对 GILD 的持仓演变
文艺复兴科技 于 Q2 2013 首次披露 GILD 持仓:196,248 股(约 US$10.1M)。 该持仓在 Q4 2019 达到峰值 16,962,944 股,市值约 US$1.10B。 在 51 次申报中,文艺复兴科技 23 次增持、25 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 2,054,876 股、市值约 US$306.3M,环比减持 -162,500 股。。 持仓曾出现大幅变动:Q1 2015 增持约 328%、Q4 2015 增持约 727%、Q4 2016 增持约 171%。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2013 | 196.25K | $10.06M | 新进 |
| Q1 2014 | 189.35K | $13.42M | 新进 |
| Q2 2014 | 166.65K | $13.82M | 减持 |
| Q4 2014 | 941.40K | $88.74M | 新进 |
| Q1 2015 | 4.03M | $395.67M | 增持 |
| Q2 2015 | 1.31M | $153.39M | 减持 |
| Q3 2015 | 280.30K | $27.52M | 减持 |
| Q4 2015 | 2.32M | $234.71M | 增持 |
| Q1 2016 | 723.95K | $66.50M | 减持 |
| Q2 2016 | 1.08M | $90.04M | 增持 |
| Q3 2016 | 1.95M | $154.05M | 增持 |
| Q4 2016 | 5.27M | $377.74M | 增持 |
| Q1 2017 | 7.71M | $523.48M | 增持 |
| Q2 2017 | 10.41M | $736.67M | 增持 |
| Q3 2017 | 10.23M | $828.91M | 减持 |
| Q4 2017 | 7.56M | $541.95M | 减持 |
| Q1 2018 | 5.03M | $379.42M | 减持 |
| Q2 2018 | 2.75M | $194.98M | 减持 |
| Q3 2018 | 4.49M | $346.65M | 增持 |
| Q4 2018 | 5.39M | $337.12M | 增持 |
| Q1 2019 | 8.12M | $527.90M | 增持 |
| Q2 2019 | 12.74M | $860.73M | 增持 |
| Q3 2019 | 14.73M | $933.86M | 增持 |
| Q4 2019 | 16.96M | $1.10B | 增持 |
| Q1 2020 | 12.53M | $936.83M | 减持 |
| Q2 2020 | 8.90M | $684.86M | 减持 |
| Q3 2020 | 7.65M | $483.52M | 减持 |
| Q4 2020 | 6.37M | $371.39M | 减持 |
| Q1 2021 | 6.56M | $424.04M | 增持 |
| Q2 2021 | 5.05M | $347.56M | 减持 |
| Q3 2021 | 5.50M | $384.24M | 增持 |
| Q4 2021 | 9.08M | $659.45M | 增持 |
| Q1 2022 | 15.49M | $921.01M | 增持 |
| Q2 2022 | 13.41M | $828.85M | 减持 |
| Q3 2022 | 10.02M | $618.29M | 减持 |
| Q4 2022 | 9.20M | $790.04M | 减持 |
| Q1 2023 | 10.58M | $878.17M | 增持 |
| Q2 2023 | 7.78M | $599.71M | 减持 |
| Q3 2023 | 6.44M | $482.87M | 减持 |
| Q4 2023 | 5.58M | $451.70M | 减持 |
| Q1 2024 | 4.32M | $316.27M | 减持 |
| Q2 2024 | 5.06M | $347.00M | 增持 |
| Q3 2024 | 4.19M | $351.17M | 减持 |
| Q4 2024 | 5.33M | $492.31M | 增持 |
| Q1 2025 | 5.45M | $610.80M | 增持 |
| Q2 2025 | 5.67M | $628.23M | 增持 |
| Q3 2025 | 5.46M | $606.36M | 减持 |
| Q4 2025 | 2.79M | $342.29M | 减持 |
| Q1 2026 | 2.15M | $300.00M | 减持 |
| Q2 2026 | 2.22M | $280.14M | 增持 |
| Q3 2026 | 2.05M | $306.28M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GILD 与 13F 数据
GILD(GILEAD SCIENCES INC)属于医疗保健行业。我们追踪的基金中还有 34 只申报持有 GILD,申报仓位最大的包括:富达投资(FMR) (US$8.68B), 景顺 (US$5.76B), Capital World Investors (US$5.36B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GILD 的基金
- 富达投资(FMR) 58.27M 股 · $8.68B · Q3 2026
- 景顺 38.66M 股 · $5.76B · Q3 2026
- Capital World Investors 35.93M 股 · $5.36B · Q3 2026
- 资本世界投资者 40.99M 股 · $5.18B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M 股 · $3.79B · Q2 2026
- Capital Research Global Investors 23.98M 股 · $3.57B · Q3 2026
- Dodge & Cox 23.68M 股 · $2.99B · Q2 2026
- DODGE & COX 23.68M 股 · $2.99B · Q2 2026
- MFS 投资管理 11.46M 股 · $1.77B · Q3 2026
- 东方汇理(美国) 11.26M 股 · $1.68B · Q3 2026
- 德意志银行 9.61M 股 · $1.43B · Q3 2026
- Boston Partners 6.52M 股 · $970.37M · Q3 2026
常见问题
How long has 文艺复兴科技 held GILD?
文艺复兴科技 has disclosed GILD holdings in 51 of the last 54 reported quarters, going back to Q2 2013.
What is 文艺复兴科技's current position in GILD?
As of Q3 2026, 文艺复兴科技 holds 2.05M shares of GILD (GILEAD SCIENCES INC), valued at $306.28M, representing 0.42% of its reported portfolio and ranking #31.
Has 文艺复兴科技 been buying or selling GILD?
In the latest 13F filing (Q3 2026), 文艺复兴科技 reduced its position in GILD. The position peaked in Q4 2019 at 16.96M shares.
Which other funds hold GILD?
Other major institutional holders of GILD include 富达投资(FMR), 景顺, Capital World Investors, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.